Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-26-000739·Vanda Pharmaceuticals Inc.
Schedule 13G ownership disclosure
Vanda Pharmaceuticals Inc
COMMON STOCK · CUSIP: 921659108
Event date: 2026-09-30
- Filing-level shares
- 3,010,531.00
- Percent of class
- 5%
- STATE STREET CORPORATION
Shares: 3,010,531.00 · Class: 5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-26-000739
- Form type
- SCHEDULE 13G
- Filer
- Vanda Pharmaceuticals Inc.
- CIK
- CIK 1347178
- Filed
- Nov 10, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership